TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 77 filers reported holding TG THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 5.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,608,320 | -65.3% | 312,000 | +3.1% | 0.00% | -60.0% |
| Q2 2023 | $7,519,068 | +67.8% | 302,700 | +1.6% | 0.01% | +66.7% |
| Q1 2023 | $4,481,920 | +13.7% | 298,000 | -10.6% | 0.00% | 0.0% |
| Q4 2022 | $3,941,756 | +104.7% | 333,200 | +2.4% | 0.00% | +200.0% |
| Q3 2022 | $1,926,000 | +41.6% | 325,400 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $1,360,000 | -50.2% | 319,900 | +11.3% | 0.00% | -50.0% |
| Q1 2022 | $2,732,000 | -46.2% | 287,300 | +7.5% | 0.00% | -33.3% |
| Q4 2021 | $5,077,000 | -42.6% | 267,200 | +0.6% | 0.00% | -50.0% |
| Q3 2021 | $8,842,000 | -11.7% | 265,700 | +2.9% | 0.01% | 0.0% |
| Q2 2021 | $10,016,000 | -13.5% | 258,200 | +7.4% | 0.01% | -25.0% |
| Q1 2021 | $11,582,000 | -2.8% | 240,300 | +4.9% | 0.01% | 0.0% |
| Q4 2020 | $11,918,000 | +98.8% | 229,100 | +2.3% | 0.01% | +60.0% |
| Q3 2020 | $5,994,000 | +75.1% | 224,000 | +27.5% | 0.01% | +66.7% |
| Q2 2020 | $3,423,000 | +100.2% | 175,700 | +1.1% | 0.00% | +50.0% |
| Q1 2020 | $1,710,000 | -5.7% | 173,800 | +6.4% | 0.00% | 0.0% |
| Q4 2019 | $1,813,000 | +110.6% | 163,300 | +6.5% | 0.00% | +100.0% |
| Q3 2019 | $861,000 | -29.1% | 153,400 | +9.2% | 0.00% | 0.0% |
| Q2 2019 | $1,215,000 | +29.0% | 140,500 | +19.9% | 0.00% | 0.0% |
| Q1 2019 | $942,000 | +95.8% | 117,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $481,000 | -21.1% | 117,200 | +7.6% | 0.00% | 0.0% |
| Q3 2018 | $610,000 | -51.8% | 108,900 | +13.2% | 0.00% | 0.0% |
| Q2 2018 | $1,265,000 | -7.4% | 96,200 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $1,366,000 | +86.6% | 96,200 | +7.7% | 0.00% | +100.0% |
| Q4 2017 | $732,000 | -30.8% | 89,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,058,000 | +32.9% | 89,300 | +12.8% | 0.00% | 0.0% |
| Q2 2017 | $796,000 | -13.8% | 79,200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $923,000 | +197.7% | 79,200 | +18.9% | 0.00% | – |
| Q4 2016 | $310,000 | -39.8% | 66,600 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $515,000 | +27.5% | 66,600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $404,000 | -13.3% | 66,600 | +17.5% | 0.00% | 0.0% |
| Q1 2016 | $466,000 | -14.3% | 56,700 | +24.3% | 0.00% | 0.0% |
| Q4 2015 | $544,000 | +18.3% | 45,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $460,000 | -20.6% | 45,600 | +30.7% | 0.00% | -50.0% |
| Q2 2015 | $579,000 | +7.2% | 34,900 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $540,000 | +40.3% | 34,900 | +43.6% | 0.00% | 0.0% |
| Q4 2014 | $385,000 | – | 24,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |